MIT engineers used kirigami-style etching to design a stent that can temporarily lodge in tubular organs to release drugs.
Professor Tim Jamison’s company Snapdragon Chemistry helps turn the latest innovations in chemistry into impactful drugs.
Natasha Joglekar ’21 is eager to apply her MIT education, with a major in computer science and biology and a minor in women’s and gender studies, to a career in medical research.
Chemical engineers have found a way to load more drug into a tablet, which could then be made smaller and easier to swallow.
Kate Kellogg advocates for “experimentalist governance,” to find what works best for employees at all levels, then implement it widely.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
Machine learning software advances could help anesthesiologists optimize drug dose.
Professor Markus Buehler composed it, and a South Korean orchestra performed it; it’s the latest in a series of artistic collaborations sparked by Buehler’s exploration of the structure of SARS-CoV-2.
Alumni-founded Multiply Labs uses an automated manufacturing platform to produce advanced treatments at scale.
Simultaneous measurement of neural rhythms and spikes across five brain areas reveals how propofol induces unconsciousness.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.